Mesenchymal Stem Cells From Adipose Tissue Do not Improve Functional Recovery After Ischemic Stroke in Hypertensive Rats

BACKGROUND AND PURPOSE—Hypertension is the most frequent comorbidity in stroke.The purpose of this study was to evaluate whether hypertension alters the response to treatment with adipose tissue-derived mesenchymal stem cells (ADMSCs) after an ischemic stroke in rats. METHODS—Ischemic stroke was ind...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2020-01, Vol.51 (1), p.342-346
Main Authors: Diekhorst, Luke, Gómez-de Frutos, Mari Carmen, Laso-García, Fernando, Otero-Ortega, Laura, Fuentes, Blanca, Jolkkonen, Jukka, Detante, Olivier, Moisan, Anaick, Leyva, Laura, Martínez-Arroyo, Arturo, Díez-Tejedor, Exuperio, Gutiérrez-Fernández, María
Format: Article
Language:English
Subjects:
Adipose Tissue - metabolism
Adipose Tissue - pathology
Allografts
Animals
Biomarkers - blood
Brain Ischemia - blood
Brain Ischemia - pathology
Brain Ischemia - therapy
Hypertension - blood
Hypertension - pathology
Hypertension - therapy
Male
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells - metabolism
Mesenchymal Stem Cells - pathology
Rats
Rats, Inbred SHR
Rats, Wistar
Stroke - blood
Stroke - pathology
Stroke - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND AND PURPOSE—Hypertension is the most frequent comorbidity in stroke.The purpose of this study was to evaluate whether hypertension alters the response to treatment with adipose tissue-derived mesenchymal stem cells (ADMSCs) after an ischemic stroke in rats. METHODS—Ischemic stroke was induced in male normotensive or hypertensive rats. Either vehicle or 1×10 ADMSC was intravenously administered at 48 hours poststroke. Functional outcome, lesion size and volume, and markers of brain repair (GFAP [glial fibrillary acidic protein], doublecortin, CD-31, α-smooth muscle actin) were evaluated. RESULTS—Hypertensive rats had larger lesions, higher apparent diffusion coefficients (ADC) and worse functional outcomes than normotensive rats. Hypertension increased GFAP and vascular markers (CD-31 and α-smooth muscle actin). The hypertensive rats treated with ADMSC did not show any significant improvement in functional recovery, lesion size, ADC values, or histological markers compared with those which received the vehicle. CONCLUSIONS—ADMSC did not reverse the hypertension-induced increase in lesion severity or functional impairment. Gliosis, neurogenesis, or vascular markers were not affected by ADMSC in hypertensive rats. Hypertension has a negative impact on the therapeutic effect of ADMSC after an ischemic stroke.
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.119.027133